Copyright
©The Author(s) 2022.
World J Gastroenterol. Jun 14, 2022; 28(22): 2417-2428
Published online Jun 14, 2022. doi: 10.3748/wjg.v28.i22.2417
Published online Jun 14, 2022. doi: 10.3748/wjg.v28.i22.2417
Study title | Phase | Status | NCT number |
MicroRNAs as diagnostic biomarkers in hepatocellular carcinoma among Somali patients | NA | Unknown | NCT03227510 |
Prospective cohort study of changes in circulatory microRNA of resected hepatocellular carcinoma | NA | Recruiting | NCT05148572 |
Clinical significance of hepatic and circulating microRNAs miR-221 and miR-222 in hepatocellular carcinoma | NA | Unknown | NCT02928627 |
Study of microRNAs as a diagnostic tool for HCV-related hepatocellular carcinoma | NA | Unknown | NCT03429530 |
Impact of IL-28B rs12979860 and rs4803217 gene polymorphisms associated with miRNAs deregulation on HCV-related hepatocellular carcinoma | NA | Unknown | NCT02507882 |
MiRNA as a diagnostic and prognostic biomarker of hepatocellular carcinoma | NA | Not yet recruiting | NCT02448056 |
Early Detection of Hepatocellular Carcinoma in a High-risk Prospective Cohort (ELEGANCE) | NA | Recruiting | NCT04965259 |
Blood sample collection for experimental blood test to track liver cancer | NA | Recruiting | NCT04720430 |
Different genetic features associated with hepatic carcinogenesis | NA | Unknown | NCT01247506 |
Genetic profiling of liver cancer in patients undergoing liver transplantation | NA | Active, not recruiting | NCT02412579 |
A study of individualized radiotherapy based on a prediction model of lymph node metastasis in hepatocellular carcinoma | NA | Unknown | NCT03416803 |
Fingerprint characterization of sorafenib treated HCC | NA | Unknown | NCT03958669 |
Risk of HCC in cirrhotic patients post DAAs treatment | NA | Unknown | NCT03414554 |
Risk of hepatocellular carcinoma in patient with liver cirrhosis | NA | Unknown | NCT03083002 |
Axitinib for the treatment of advanced hepatocellular carcinoma | 2 | Completed | NCT01210495 |
The phase III study of icaritin versus sorafenib in PD-L1 positive advanced hepatocellular carcinoma subjects | 3 | Recruiting | NCT03236649 |
The phase III study of icaritin versus HUACHANSU PIAN in hepatocellular carcinoma subjects | 3 | Recruiting | NCT03236636 |
A study of rSIFN-co in subjects with advanced solid tumors | 1 | Completed | NCT02387307 |
Stereotactic body radiation therapy and transarterial chemoembolization in treating patients with liver cancer that cannot be removed by surgery | 1 | Completed | NCT02507765 |
Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary-tract cancer | 2 | Active, not recruiting | NCT03044587 |
- Citation: Badami E, Busà R, Douradinha B, Russelli G, Miceli V, Gallo A, Zito G, Conaldi PG, Iannolo G. Hepatocellular carcinoma, hepatitis C virus infection and miRNA involvement: Perspectives for new therapeutic approaches. World J Gastroenterol 2022; 28(22): 2417-2428
- URL: https://www.wjgnet.com/1007-9327/full/v28/i22/2417.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i22.2417